|1||NCT03257761||Recruiting||Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer||
||Other / NIH||
||90||All||18 Years and older (Adult, Older Adult)||NCT03257761||0S-16-18
|February 7, 2018||February 7, 2021||February 20, 2022||August 22, 2017||May 3, 2019||
|Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)||
||28||All||18 Years and older (Adult, Older Adult)||NCT02082522||PIN-PHO1201||November 12, 2014||January 12, 2017||January 12, 2017||March 10, 2014||August 26, 2019||August 26, 2019||
† Study has passed its completion date and status has not been verified in more than two years.